Buy Taiwan Liposome Company Ltd - ADR Stock | TLC Stock Price & Latest News | Public.com
TLC

Taiwan Liposome Company Ltd - ADR

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View Taiwan Liposome Company Ltd - ADR (TLC) stock trends here

    About TLC

    Taiwan Liposome Co., Ltd. engages in the research and development of lipid-based formulation drugs. Its products are used for pain management, eye disease treatment, and cancer treatment. The company was founded by Kee Lung Hong on November 10, 1997 and is headquartered...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.08
    -0.16
    -0.24
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    -$0.16

    Actual EPS
    Q1 2021

    Stats

    Market Cap$224,66M
    Volume7,76k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$12.65
    1 Year Low$2.48
    Open$5.45
    High$5.50
    Low$5.34

    Buy any stock with any amount of money.

    Download the App
    Download the app